shenzhenshiyifengdianzishangwuyouxiangongsi – Trademark Portfolio

Entity Type: 99

shenzhenshiyifengdianzishangwuyouxiangongsi holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CLIFORT. The owner is based in shenzhenshi.

baoanqusonggangjiedaoxitoushequbagongye

quxiliuxiang20hao723,

shenzhenshi 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLIFORT
CLIFORT
Registered 2021

Trademark Classifications

shenzhenshiyifengdianzishangwuyouxiangongsi's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does shenzhenshiyifengdianzishangwuyouxiangongsi have?

shenzhenshiyifengdianzishangwuyouxiangongsi has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does shenzhenshiyifengdianzishangwuyouxiangongsi file in?

shenzhenshiyifengdianzishangwuyouxiangongsi files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are shenzhenshiyifengdianzishangwuyouxiangongsi's most well-known trademarks?

shenzhenshiyifengdianzishangwuyouxiangongsi's registered trademark portfolio includes well-known marks such as CLIFORT. These are among 1 currently registered trademark in the portfolio.

What is shenzhenshiyifengdianzishangwuyouxiangongsi's trademark registration success rate?

shenzhenshiyifengdianzishangwuyouxiangongsi has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.